{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:57:03Z","timestamp":1757591823155},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,12,7]],"date-time":"2005-12-07T00:00:00Z","timestamp":1133913600000},"content-version":"vor","delay-in-days":4299,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[1994,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antibodies to the hepatitis C virus (HCV) core of various immunoglobulin classes were determined by enzyme immunoassays with three synthetic peptides, CP14 (amino acids 5\u201040 of the core protein), CP10 (5\u201023), and CP9 (39\u201074). In 135 patients with chronic type C liver disease, anti\u2010CPU, anti\u2010CP10, and anti\u2010CP9 of IgG class were detected in 99%, 94%, 82%, respectively; those of IgM class in 86%, 69%, and 39%; and those of IgA class in 56%, 40%, and 4%. Thus anti\u2010CP14 was more prevalent than anti\u2010CPlO or anti\u2010CP9 in every immunoglobulin class. The prevalence of IgM anti\u2010CP14 was much higher (<jats:italic>P<\/jats:italic> &lt; 0.001) in patients (116\/135 or 86%) than in asymptomatic carriers of HCV (13\/39 or 33%). In seven patients with acute hepatitis C, IgM anti\u2010CP14 continued to decrease in two in whom hepatitis resolved, but increased in five in whom hepatitis once resolved and then exacerbated. IgM anti\u2010CP14 was followed in 30 patients with chronic hepatitis C during 24 weeks while they received recombinant interferon \u03b1\u20102a. IgM anti\u2010CP14 decreased remarkably within 8 weeks in all of them. Thereafter, it continued to decrease in nine patients who responded to interferon and lost HCV RNA from circulation, but started to increase in five non\u2010responders who continued to have high titers of HCV RNA. In the remaining 16 patients in whom HCV RNA decreased once and then increased, IgM anti\u2010CP14 continued to decrease till 20 weeks and then increased. These results indicate that IgM anti\u2010CP14 reflects the activity of liver disease, and is useful in following the outcome of patients with acute hepatitis C and in monitoring the response to interferon in patients with chronic hepatitis C. \u00a9 1994 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jmv.1890420320","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T23:31:42Z","timestamp":1172878302000},"page":"311-317","source":"Crossref","is-referenced-by-count":22,"title":["IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C"],"prefix":"10.1002","volume":"42","author":[{"given":"Ryozo","family":"Nagayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,7]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111073251901"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911303212202"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.1990.03450170079026","article-title":"Risk factors for acute non\u2010A, non\u2010B hepatitis in the United States and association with hepatitis C virus antibody","volume":"264","author":"Alter MJ","year":"1990","journal-title":"Journal of American Medical Association"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212313272702"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890360314"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150604"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(91)90075-B"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.13.5971"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.1.169.169"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/76.2.140"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.255.11.1443"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890390412"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32993110750.x"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2496467"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(82)90003-8"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/143.6.803"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150105"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.12.5462"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0016-5085(85)90217-3","article-title":"Immunoglobulin A antibody against hepatitis B core antigen in the acute and persistent infection with hepatitis B virus","volume":"89","author":"Nomura M","year":"1985","journal-title":"Gastroenterology"},{"key":"e_1_2_1_22_1","first-page":"167","article-title":"The 5\u2032\u2010terminal sequence of the hepatitis C virus genome","volume":"60","author":"Okamoto H","year":"1990","journal-title":"Japanese Journal of Experimental Medicine"},{"key":"e_1_2_1_23_1","first-page":"223","article-title":"Enzyme\u2010linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide","volume":"60","author":"Okamoto H","year":"1990","journal-title":"Japanese Journal of Experimental Medicine"},{"key":"e_1_2_1_24_1","first-page":"215","article-title":"Detection of hepatitis C virus RNA by a two\u2010stage poly\u2010merase chain reaction with two pairs of primers deduced from the 5\u2032\u2010noncoding region","volume":"60","author":"Okamoto H","year":"1990","journal-title":"Japanese Journal of Experimental Medicine"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150203"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840140107"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91517-8"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/jcm.30.8.1989-1994.1992","article-title":"Immunodominant regions with the hepatitis C virus core and putative matrix proteins","volume":"30","author":"Sallberg M","year":"1992","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_1_29_1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0016-5085(83)90086-0","article-title":"Immunoglobulin M antibody against hepatitis B core antigen for the diagnosis of fulminant type B hepatitis","volume":"84","author":"Shimizu M","year":"1983","journal-title":"Gastroenterology"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(85)90323-3"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(84)90139-2"},{"key":"e_1_2_1_32_1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/jcm.30.3.552-556.1992","article-title":"Serological markers of posttransfusion hepatitis C viral infection","volume":"30","author":"Vallari DS","year":"1992","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90942-I"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.1890420320","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.1890420320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T20:37:50Z","timestamp":1698179870000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.1890420320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["10.1002\/jmv.1890420320"],"URL":"https:\/\/doi.org\/10.1002\/jmv.1890420320","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}